Increased percentage and the absolute number of Lin–/lowHLA-DR–CD11b+CD33+ MDSCs compared with healthy controls. This increase is closely correlated with clinical cancer stage and tumor metastasis but not primary tumor size. Here, CD33 is linked to cancer.